D-Index & Metrics Best Publications

Clive P. Page

King's College London
United Kingdom

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Immunology D-index 77 Citations 18,818 421 World Ranking 1166 National Ranking 101

Medicine D-index 86 Citations 26,231 617 World Ranking 9195 National Ranking 878

Overview

What is he best known for?

The fields of study he is best known for:

Internal medicine
Enzyme
Pharmacology

His primary areas of investigation include Immunology, Pharmacology, Asthma, Platelet and Internal medicine. His studies examine the connections between Immunology and genetics, as well as such issues in Bronchoalveolar lavage, with regards to Intensive care and Antigen. His work deals with themes such as In vivo, Phosphodiesterase, Phosphodiesterase 3 and Heparin, which intersect with Pharmacology.

The Asthma study combines topics in areas such as COPD, Theophylline and Bronchial hyperresponsiveness. His study in Platelet is interdisciplinary in nature, drawing from both Eosinophil, Chemotaxis, Nitric oxide and Allergic inflammation. His Internal medicine research incorporates themes from Gastroenterology, Placebo, Endocrinology and Sputum.

His most cited work include:

Inflammatory mediators of asthma: an update. (672 citations)
Outcomes for COPD pharmacological trials: From lung function to biomarkers (654 citations)
The future challenges facing the development of new antimicrobial drugs. (466 citations)

What are the main themes of his work throughout his whole career to date?

Clive P. Page mainly investigates Immunology, Pharmacology, Internal medicine, Platelet and Asthma. His Immunology study combines topics in areas such as Lung and Histamine. His Histamine research incorporates elements of Bronchoconstriction and Bronchoalveolar lavage.

His Pharmacology research integrates issues from In vivo, Bronchodilator and Heparin. His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology. His Asthma research is multidisciplinary, incorporating elements of Respiratory disease, Bronchial hyperresponsiveness and COPD.

He most often published in these fields:

Immunology (36.14%)
Pharmacology (29.60%)
Internal medicine (22.12%)

What were the highlights of his more recent work (between 2013-2021)?

Pharmacology (29.60%)
COPD (11.99%)
Immunology (36.14%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Pharmacology, COPD, Immunology, Lung and Asthma. The various areas that Clive P. Page examines in his Pharmacology study include Heparin, In vivo, Bronchodilator and Respiratory system. His COPD study is concerned with Internal medicine in general.

His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Endocrinology. His research on Immunology frequently links to adjacent areas such as Bronchial hyperresponsiveness. Clive P. Page interconnects Inhalation, Nasal administration and Pathology in the investigation of issues within Lung.

Between 2013 and 2021, his most popular works were:

Pharmacology of Heparin and Related Drugs (143 citations)
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis (97 citations)
Antitussive drugs--past, present, and future (85 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Inflammatory mediators of asthma: an update.

P J Barnes;K F Chung;C P Page.
Pharmacological Reviews (1998)

1100 Citations

Outcomes for COPD pharmacological trials: From lung function to biomarkers

M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe.
European Respiratory Journal (2008)

1023 Citations

The future challenges facing the development of new antimicrobial drugs

Anthony Coates;Yanmin Hu;Richard Bax;Clive Page.
Nature Reviews Drug Discovery (2002)

812 Citations

Inflammatory mediators and asthma.

P J Barnes;K F Chung;C P Page.
Pharmacological Reviews (1988)

598 Citations

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

P. Sullivan;Z. Jaffar;C. Page;J. Costello.
The Lancet (1994)

519 Citations

Pharmacology and Therapeutics of Bronchodilators

Mario Cazzola;Clive P. Page;Luigino Calzetta;M. Gabriella Matera.
Pharmacological Reviews (2012)

452 Citations

Novel drug development opportunities for heparin

Rebecca Lever;Clive P. Page.
Nature Reviews Drug Discovery (2002)

418 Citations

Pulmonary biomarkers in chronic obstructive pulmonary disease

Peter J. Barnes;Badrul Chowdhury;Sergei A. Kharitonov;Helgo Magnussen.
American Journal of Respiratory and Critical Care Medicine (2006)

392 Citations

EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN

K.F. Chung;M. Mccusker;C.P. Page;G. Dent.
The Lancet (1987)

378 Citations

Phosphodiesterase inhibitors: Phosphodiesterase inhibitors

Victoria Boswell-Smith;Domenico Spina;Clive P Page.
British Journal of Pharmacology (2006)

364 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Clive P. Page